Newsroom

Research

Oneil Fc
Study: Private hospital rooms lower risk of infectionsBy Sally Crocker Private hospital rooms may save lives by reducing the risk of a dangerous type of hospital-acquired infection, according to UNT Health Science Center researchers in a new study published in PLOS ONE. Liam O’Neill, PhD, Associate Professor of Health Behavior and Health Systems at the UNTHSC School of Public Health, led the Read More »

Aug 14, 2018

Research Team Fc
Research for the long haulBy Jan Jarvis Scientific breakthroughs once belonged to the young. Or at least that’s what Einstein must have thought when he said that unless a scientist has made a great contribution before the age of 30, he never will. Time, however, has proven him wrong. Robert Edwards, for example, was 85 when he developed in Read More »

Aug 2, 2018

Walters Fc
Researchers will use smartphone app to improve alcohol treatmentBy Sally Crocker Researchers from UNT Health Science Center and the University of Oklahoma Health Sciences Center (OUHSC) have been awarded a two-year, $650,000 National Institutes of Health (NIH) grant to develop and test a novel smartphone-based alcohol treatment for homeless adults. Scott Walters, PhD, Professor and Chair of Health Behavior and Health Systems at the Read More »

Jul 31, 2018

Jerry Simecka
Relieving the pain of peripheral arterial diseaseBy Jan Jarvis For someone with peripheral arterial disease – a condition that causes narrowing of arteries in the limbs – pain is a big problem. “The treatment for it is exercise,” said Eric Gonzales, PhD, Associate Professor in the Department of Medical Education in the TCU and UNTHSC School of Medicine, which is pending Read More »

Jul 19, 2018

Sid Fc
A blood test that IDs Alzheimer’s earlier, easier and cheaperBy Jan Jarvis   The first study of a blood test to detect Alzheimer’s disease within a primary care setting soon will be conducted at UNT Health Science Center. The simple test could be a game-changer in the diagnosis of early Alzheimer’s. If successful, it would be possible to identify patients earlier, easier and at Read More »

Jul 12, 2018

Zode Fc
Research opens new doors to treating glaucomaBy Jan Jarvis Glucocorticoids are often used to reduce inflammation, reduce pain and treat many conditions such as allergies and rashes. But for some people, the very drugs that treats one condition can cause another: specifically, glaucoma. The condition, which affects more than 64.3 million people, is the second-leading cause of irreversible blindness in the Read More »

Jun 26, 2018

Lee Fc
Mosquito monitoring protects Fort Worth again this yearBy Sally Crocker   While most people do everything they can to avoid mosquitos in the summer, medical entomologist Joon-Hak Lee, PhD, goes out of his way to track them down. Dr. Lee, an Associate Professor of Biostatistics and Epidemiology at the UNT Health Science Center School of Public Health, has spent the last six Read More »

Jun 21, 2018

Charles and Teresa Gonzales
A population at riskBy Jan Jarvis   Charles and Teresa Gonzales know what dementia does to a person. The Grand Prairie couple has lived through it with both of their mothers. “The first thing I noticed was my mother kept asking the same question over and over,” Charles said. “She’d ask something and a few minutes later, ask Read More »

Jun 19, 2018

Dr. Cunningham in the lab
Fighting a deadly side effect of heart failureByJan Jarvis   For many of the 6.5 million people who live with heart failure, developing water retention related to their disease will decrease their chances of survival. Although many patients with water retention are treated with diuretics, it is not known why they develop the condition, said Tom Cunningham, PhD, Regents Professor of Physiology Read More »

Jun 11, 2018

Andras Lacko, PhD researches HDL Drug Delivery
Partnership explores using HDL as a tool for delivering drugsBy Jan Jarvis   UNT Health Science Center has joined with the international biopharmaceutical company Cerenis Therapeutics to develop HDL-based drug delivery systems for treating cardiovascular and metabolic diseases. The joint strategic partnership called the “HDL Drug Delivery Initiative” will leverage the expertise of the research team led by Andras Lacko, PhD, Professor of Physiology Read More »

May 29, 2018